T1/ST2 promotes T helper 2 cell activation and polyfunctionality in bronchopulmonary mycosis

Mucosal Immunology

Volumn 6, Issue 2, 2013, Pages 405-414

  Piehler, D ^a   Grahnert, A ^a   Eschke, M ^a   Richter, T ^a   Kohler G ^b   Stenzel, W ^c   Alber, G ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN; INTERLEUKIN 13; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 5; L SELECTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; CYTOKINE PRODUCTION; DOWN REGULATION; FEMALE; FUNGUS IMMUNITY; LUNG MYCOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY CRYPTOCOCCOSIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TH2 CELL; UPREGULATION;

EID: 84874030444     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2012.84     Document Type: Article

References (52)

1. Loures, F. V., Pina, A., Felonato, M. & Calich, V. L. TLR2 is a negative regulator of Th17 cells and tissue pathology in a pulmonary model of fungal infection. J. Immunol. 183, 1279-1290 (2009).
2. Stuehler, C. et al. Cross-protective TH1 immunity against Aspergillus fumigatus and Candida albicans. Blood 117, 5881-5891 (2011).
3. Wuthrich, M., Deepe, G. & Klein, B. Adaptive immunity to fungi. Annu. Rev. Immunol. 30, 115-148 (2012).
4. Doherty, T. A. et al. Alternaria induces STAT6-dependent acute airway eosinophilia and epithelial FIZZ1 expression that promotes airway fibrosis and epithelial thickness. J. Immunol. 188, 2622-2629 (2012).
5. Goldman, D. L. et al. Increased chitinase expression and fungal-specific antibodies in the bronchoalveolar lavage fluid of asthmatic children. Clin. Exp. Allergy 42, 523-530 (2012).
6. Ramaprakash, H. et al. Targeting ST2L potentiates CpG-mediated therapeutic effects in a chronic fungal asthma model. Am. J. Pathol. 179, 104-115 (2011).
7. Park, B. J. et al. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23, 525-530 (2009).
8. Hernandez, Y. et al. Distinct roles for IL-4 and IL-10 in regulating T2 immunity during allergic bronchopulmonary mycosis. J. Immunol. 174, 1027-1036 (2005).
9. Huffnagle, G. B., Boyd, M. B., Street, N. E. & Lipscomb, M. F. IL-5 is required for eosinophil recruitment, crystal deposition, and mononuclear cell recruit ment during a pulmonary Cryptococcus neoformans infection in genetically susceptible mice (C57BL/6). J. Immunol. 160, 2393-2400 (1998).
10. Muller, U. et al. IL-13 induces disease-promoting type 2 cytokines, alternatively activated macrophages and allergic inflammation during pulmonary infection of mice with Cryptococcus neoformans. J. Immunol. 179, 5367-5377 (2007).
11. Muller, U. et al. A gene-dosage effect for interleukin-4 receptor alpha-chain expression has an impact on Th2-mediated allergic inflammation during bronchopulmonary mycosis. J. Infect. Dis. 198, 1714-1721 (2008).
12. Stenzel, W. et al. IL-4/IL-13-dependent alternative activation of macrophages but not microglial cells is associated with uncontrolled cerebral cryptococcosis. Am. J. Pathol. 174, 486-496 (2009).
13. Piehler, D. et al. Eosinophils contribute to IL-4 production and shape the T-helper cytokine profile and inflammatory response in pulmonary cryptococcosis. Am. J. Pathol. 179, 733-744 (2011).
14. Carriere, V. et al. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc. Natl. Acad. Sci. USA 104, 282-287 (2007).
15. Schmitz, J. et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23, 479-490 (2005).
16. Zaiss, M. M. et al. IL-33 shifts the balance from osteoclast to alternatively activated macrophage differentiation and protects from TNF-alphamediated bone loss. J. Immunol. 186, 6097-6105 (2011).
17. Granne, I. et al. ST2 and IL-33 in pregnancy and pre-eclampsia. PLoS One 6, e24463 (2011).
18. Nelson, M. P. et al. IL-33 and M2a alveolar macrophages promote lung defense against the atypical fungal pathogen Pneumocystis murina. J. Immunol. 186, 2372-2381 (2011).
19. Kouzaki, H., Iijima, K., Kobayashi, T., O'Grady, S. M. & Kita, H. The danger signal, extracellular ATP, is a sensor for an airborne allergen and triggers IL-33 release and innate Th2-type responses. J. Immunol. 186, 4375-4387 (2011).
20. Kondo, Y. et al. Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. Int. J. Immunol. 20, 791-800 (2008).
21. Townsend, M. J., Fallon, P. G., Matthews, D. J., Jolin, H. E. & McKenzie, A. N. T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses. J. Exp. Med. 191, 1069-1076 (2000).
22. Wynn, T. A. IL-13 effector functions. Annu. Rev. Immunol. 21, 425-456 (2003).
23. Rothenberg, M. E. & Hogan, S. P. The eosinophil. Annu. Rev. Immunol. 24, 147-174 (2006).
24. Decken, K. et al. Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans. Infect. Immun. 66, 4994-5000 (1998).
25. Walzl, G. et al. Inhibition of T1/ST2 during respiratory syncytial virus infection prevents T helper cell type 2 (Th2)- but not Th1-driven immunopathology. J. Exp. Med. 193, 785-792 (2001).
26. Lohning, M. et al. T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc. Natl. Acad. Sci. USA 95, 6930-6935 (1998).
27. Kropf, P., Bickle, Q., Herath, S., Klemenz, R. & Muller, I. Organ-specific distribution of CD4+ T1/ST2+ Th2 cells in Leishmania major infection. Eur. J. Immunol. 32, 2450-2459 (2002).
28. Muller, U. et al. Lack of IL-4 receptor expression on T helper cells reduces T helper 2 cell polyfunctionality and confers resistance in allergic bronchopulmonary mycosis. Mucosal Immunol. 5, 299-310 (2012).
29. Lohning, M. et al. T1/ST2 expression is enhanced on CD4+ T cells from schistosome egg-induced granulomas: analysis of Th cell cytokine coexpression ex vivo. J. Immunol. 162, 3882-3889 (1999).
30. Kawakami, K. et al. IL-18 contributes to host resistance against infection with Cryptococcus neoformans in mice with defective IL-12 synthesis through induction of IFN-gamma production by NK cells. J. Immunol. 165, 941-947 (2000).
31. Darrah, P. A. et al. Multifunctional TH1 cells define a correlate of vaccinemediated protection against Leishmania major. Nat. Med. 13, 843-850 (2007).
32. Frentsch, M. et al. Direct access to CD4+ T cells specific for defined antigens according to CD154 expression. Nat. Med. 11, 1118-1124 (2005).
33. Herring, A. C., Lee, J., McDonald, R. A., Toews, G. B. & Huffnagle, G. B. Induction of interleukin-12 and gamma interferon requires tumor necrosis factor alpha for protective T1-cell-mediated immunity to pulmonary Cryptococcus neoformans infection. Infect. Immun. 70, 2959-2964 (2002).
34. Willerford, D. M. et al. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3, 521-530 (1995).
35. Cote-Sierra, J. et al. Interleukin 2 plays a central role in Th2 differentiation. Proc. Natl. Acad. Sci. USA 101, 3880-3885 (2004).
36. Liao, W. et al. Priming for T helper type 2 differentiation by interleukin 2-mediated induction of interleukin 4 receptor alpha-chain expression. Nat. Immunol. 9, 1288-1296 (2008).
37. Meisel, C. et al. Regulation and function of T1/ST2 expression on CD4+ T cells: induction of type 2 cytokine production by T1/ST2 cross-linking. J. Immunol. 166, 3143-3150 (2001).
38. Gillis, S., Ferm, M. M., Ou, W. & Smith, K. A. T cell growth factor: parameters of production and a quantitative microassay for activity. J. Immunol. 120, 2027-2032 (1978).
39. Kurowska-Stolarska, M. et al. IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4. J. Immunol. 181, 4780-4790 (2008).
40. Guo, L. et al. IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells. Proc. Natl. Acad. Sci. USA 106, 13463-13468 (2009).
41. Kropf, P., Herath, S., Klemenz, R. & Muller, I. Signaling through the T1/ST2 molecule is not necessary for Th2 differentiation but is important for the regulation of type 1 responses in nonhealing Leishmania major infection. Infect. Immun. 71, 1961-1971 (2003).
42. Hoshino, K. et al. The absence of interleukin 1 receptor-related T1/ST2 does not affect T helper cell type 2 development and its effector function. J. Exp. Med. 190, 1541-1548 (1999).
43. Fort, M. M. et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15, 985-995 (2001).
44. Al-Shami, A., Spolski, R., Kelly, J., Keane-Myers, A. & Leonard, W. J. A role for TSLP in the development of inflammation in an asthma model. J. Exp. Med. 202, 829-839 (2005).
45. Grunig, G. et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282, 2261-2263 (1998).
46. Tominaga, A. et al. Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production. J. Exp. Med. 173, 429-437 (1991).
47. Moro, K. et al. Innate production of T(H)2 cytokines by adipose tissueassociated c-Kit(+)Sca-1(+) lymphoid cells. Nature 463, 540-544 (2010).
48. Neill, D. R. et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464, 1367-1370 (2010).
49. Price, A. E. et al. Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc. Natl. Acad. Sci. USA 107, 11489-11494 (2010).
50. Saenz, S. A. et al. IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses. Nature 464, 1362-1366 (2010).
51. Kleinschek, M. A. et al. IL-23 enhances the inflammatory cell response in Cryptococcus neoformans infection and induces a cytokine pattern distinct from IL-12. J. Immunol. 176, 1098-1106 (2006).
52. Fulkerson, P. C. et al. A central regulatory role for eosinophils and the eotaxin/CCR3 axis in chronic experimental allergic airway inflammation. Proc. Natl. Acad. Sci. USA 103, 16418-16423 (2006).